This inventor holds 1 USPTO granted patent. Top assignees: Centro Biotecnologie Avanzate, Universitá Degli Studi Di Genova. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Ernesto Fattorusso
Introduction
Ernesto Fattorusso is a notable inventor based in Naples, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of novel adenyl dinucleotides with antitumour activity. His work has implications for cancer treatment, especially for haematological malignancies.
Latest Patents
Fattorusso holds a patent for "Adenyl dinucleotides with antitumour activity and a method of preparing thereof." This invention relates to new adenyl dinucleotides that are isomers of the dinucleotide Ap2A. The dinucleotides exhibit antitumour activity, particularly against leukaemias and lymphomas. The patent also describes an enzymatic method for preparing these dinucleotides and an assay method based on their conversion to NAD.
Career Highlights
Throughout his career, Ernesto Fattorusso has worked with esteemed institutions such as the University of Genoa and the Advanced Biotechnology Center. His research has focused on the biochemical properties of nucleotides and their potential therapeutic applications.
Collaborations
Fattorusso has collaborated with notable colleagues, including Giovanna Basile and Umberto Benatti. Their joint efforts have contributed to advancements in the understanding of nucleotide biochemistry.
Conclusion
Ernesto Fattorusso's innovative work in the field of biochemistry has the potential to impact cancer treatment significantly. His patent on adenyl dinucleotides showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile